Company Filing History:
Years Active: 2013
Title: The Innovations of Kyung-Hyan Min
Introduction
Kyung-Hyan Min is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target central nervous system disorders. His work is characterized by a focus on innovative solutions for mental health issues.
Latest Patents
Kyung-Hyan Min holds a patent for racemic or enantiomerically enriched 3- or 4-substituted piperidine compounds. These compounds are represented by a specific structural formula and include their isomers and pharmaceutically acceptable salts. The patent outlines the utility of these compounds in treating diseases of the central nervous system, including depression, anxiety, and pain disorders. This innovation highlights the potential for new therapeutic options in mental health treatment.
Career Highlights
Min is currently associated with Sk Biopharmaceuticals Co., Ltd., where he continues to advance his research and development efforts. His work at this company underscores his commitment to creating effective pharmaceutical solutions. With a focus on innovative compounds, he aims to address pressing health challenges.
Collaborations
Throughout his career, Kyung-Hyan Min has collaborated with esteemed colleagues, including Ki-Ho Lee and Chun-Eung Park. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Kyung-Hyan Min's contributions to the field of pharmaceutical chemistry are noteworthy, particularly his innovative work on piperidine compounds for central nervous system disorders. His ongoing efforts at Sk Biopharmaceuticals Co., Ltd. reflect his dedication to improving mental health treatment options.